Search results
BioNTech and CEPI expand deal to boost Africa’s vaccine capabilities
Pharmaceutical Technology via Yahoo Finance· 13 hours agoBioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced an expansion...
BioNTech gets $145 million funding for African vaccine plants
Reuters via Yahoo News· 1 day agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate
Zacks via Yahoo Finance· 2 years agoEmergent BioSolutions EBS announced the dosing of the first patient in a phase I study evaluating...
Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious...
Benzinga via Yahoo Finance· 2 years agoInovio Pharmaceuticals Inc (NASDAQ: INO) has agreed with its collaborator, the Coalition for...
British agencies win CEPI funds to develop standard monkeypox tools
Reuters via Yahoo News· 2 years agoLONDON (Reuters) -British health agencies have secured funding to develop a standardised approach to...
COVID-19 vaccine scheme for poorest has $2.6bn left to spend as pandemic recedes
Reuters via Yahoo News· 11 months agoSeveral billions of dollars left in a scheme to deliver COVID-19 vaccines to the world’s poorest...
BioNTech wins up to $90 million in funding for mpox vaccine development
Reuters via AOL· 8 months agoBioNTech would initiate an early-to-mid stage trial for the vaccine program BNT166 to prevent mpox,...
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line
Politico via Yahoo News· 2 years agoBiden administration officials are raising concerns that the slow pace of developing a nasal vaccine...
Why the U.S. Doesn’t Have a Nasal Vaccine for COVID-19
Time via Yahoo News· 2 years agoCredit - Illustration by Alex Nabaum for TIME The U.S. led the world in quickly developing COVID-19...
Almost $1.9 billion left in COVID vaccine scheme for future health efforts -Germany
Reuters via Yahoo News· 11 months agoAlmost $1.9 billion left in the global scheme to share COVID-19 vaccines more equitably will be used...